Titan Medical Announces Resignation of Domenic Serafino
“Dom has been a valuable member of Titan’s Board of Directors since June of 2018. We thank him for his service to our Company and our shareholders, and extend best wishes for continued professional success,” said David McNally, President, and CEO of Titan Medical.
FDA Grants De Novo Clearance to Bluegrass Vascular Technologies for the Surfacer® Inside-Out® Access Catheter System
The company reports that the Surfacer System will be available in select U.S. centers in the coming months. The system received CE Mark in 2016 and is available in Europe, Canada, Singapore and the Middle East.
Soliton Files Special 510(k) with FDA for its Generation II RAP Acoustic Pulse Device
The Generation II RAP Acoustic Pulse Device delivers the same tattoo-removal therapy as the Generation I device, but is slightly modified for improved ease of use in the physician's office.
BD Completes Clinical Trial for BD Libertas Wearable Injector Completed
The award-winning Libertas Wearable Injector is a subcutaneous drug delivery system, currently in development, that is designed to require no patient assembly and deliver biologics with viscosities up to 50 cP in 2-5 mL and 5-10 mL configurations.
DYSIS Medical Announces John Pedersen Named Chairman of the Board
DYSIS Medical advises prior to joining Augmenix, Pedersen served as a Senior Healthcare Advisor for two healthcare private equity funds – The Gores Group and The Pritzker Group.